Clinical trial Recruiting at 6 sites Interventional Ages 20 to 40 Women only

Constant 5% versus sequential 5% to 2% oxygen for embryo culture in IVF

Official title: A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology: Evaluating Term Live Birth and Offspring Health Outcomes

Run by The First Affiliated Hospital with Nanjing Medical University · NCT07050537 · Data updated 2026-11-12

This will test whether keeping embryos at a constant 5% oxygen level or lowering oxygen from 5% to 2% during culture changes term live birth rates for women undergoing blastocyst IVF.

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexWomen only
Enrollment980 (estimated)
SponsorThe First Affiliated Hospital with Nanjing Medical University
Academic / other
Locations6 sites (Zhengzhou, Henan and 5 other locations)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedMarch 31, 2027
Study endsAugust 31, 2027
Registry record updatedJune 1, 2026
Trial IDNCT07050537 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 20–40 undergoing their first or second IVF/ICSI cycle who produce at least four transferable oocytes and plan blastocyst transfer are ideal candidates.

Probably not a fit

Patients with uterine anatomical abnormalities, plans for IVM or PGD/PGS, untreated severe hydrosalpinx, a history of recurrent miscarriage, or those freezing all embryos without completing a single transfer within six months are unlikely to benefit from this protocol comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a multicenter, randomized controlled design, about 980 women planning blastocyst transfer will be assigned to embryo culture under either a constant 5% oxygen environment or a sequential 5%→2% oxygen protocol. The trial will be conducted at five Chinese reproductive centers using standard IVF/ICSI procedures with random allocation at the embryo culture stage. Primary outcome is term live birth rate, and secondary outcomes include perinatal complications and offspring telomere length and health measures. All data will be analyzed statistically to compare clinical and offspring outcomes between the two oxygen regimens.

Why it matters

Potential benefit: If successful, the preferred oxygen protocol could increase term live birth rates and help preserve offspring telomere length, potentially improving long-term child health.

How similar studies have gone: Laboratory and some clinical work suggest low-oxygen (≈5%) culture improves embryo development and pregnancy outcomes versus atmospheric oxygen, but randomized data directly comparing constant 5% to sequential 5%→2% culture and effects on offspring telomere length are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female: age ≥20 and ≤40 years, male: age ≥20 and ≤50 years;
2. Proposed 1st or 2nd cycle of IVF or ICSI fertilization;
3. ≥ 4 transferable embryos at oocyte stage.

Exclusion Criteria:

1. Diagnosis of abnormal uterine cavity morphology (confirmed by 3D ultrasound or hysteroscopy), including uterine malformations (mediastinal uterus, unicornuate uterus, bicornuate uterus), submucosal uterine fibroids, or uterine adhesions;
2. Patients who are proposed to undergo IVM;
3. Patients who are proposed to undergo PGD/ PGS;
4. Patients with untreated severe hydrosalpinx (confirmed by ultrasound or HSG);
5. Patients with a history of recurrent miscarriage (2 or more previous pregnancy losses, excluding biochemical pregnancies);
6. Patients who plan to freeze whole embryos and are unable to complete a single embryo transfer within six months;
7. Patients with contraindications to assisted reproductive technology and pregnancy, or suffering from diseases that have a definite effect on pregnancy: including uncontrolled hypertension, heart disease with definite symptoms, uncontrolled diabetes, undefined diagnosis of liver or kidney disease or liver or kidney insufficiency, severe anemia, history of previous venous thrombosis, pulmonary embolism or cerebrovascular events, history of malignant tumors, suspected malignant tumors, and undiagnosed abnormal uterine bleeding.

Where it's running

  • The Third Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan, China
    Recruiting
  • Changzhou Maternal And Child Health Care Hospital
    Changzhou, Jiangsu, China
    Recruiting
  • Nanjing Women and Children's Healthcare Hospital
    Nanjing, Jiangsu, China
    Recruiting
  • Reproductive Medicine of First Affiliated Hospital with Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting
  • Suzhou Municipal Hospital
    Suzhou, Jiangsu, China
    Recruiting
  • Northwest Women's and Children's Hospital
    Xi’an, Shanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • FRAME support for women undergoing fertility care

    This pilot will test whether giving women access to the FRAME app and an external support team for six months reduces stress and improves emotional well-being during fertility care.

    Recruiting Inception Fertility Research Institute, LLC · Houston, Texas · NCT07083700

  • Examining how tucking affects semen quality in trans women

    This study is testing how tucking affects sperm quality in trans women who want to preserve their fertility before starting hormone therapy.

    Recruiting Medical University Innsbruck · Innsbruck · NCT06530992

  • Cryopreservation of testicular tissue for fertility preservation

    This study is testing whether freezing testicular tissue can help men at risk of infertility due to illness or treatment keep their options open for having children in the future.

    Recruiting University of Colorado, Denver · Aurora, Colorado · NCT06387498

  • Exploring fertility preservation and health outcomes in female cancer patients

    This study is testing if women with cancer who take steps to save their ability to have children before treatment have better chances of having healthy babies compared to those who don’t and to women without cancer.

    Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06360471

  • Exploring male factors affecting fertility and pregnancy likelihood

    This study is trying to find out how different male factors affect the chances of getting pregnant for couples, to help create a tool that predicts pregnancy rates and improve reproductive health.

    Recruiting KK Women's and Children's Hospital · Singapore · NCT06293235

  • Evaluating outcomes after fertility preservation methods

    This study looks at how well different fertility preservation methods work for people who have had cancer or other fertility issues, using their medical records to see what factors might affect their success.

    Recruiting Chinese University of Hong Kong · Hong Kong · NCT06043609

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.